LEADER 04934nam 2200613Ia 450 001 9910959306703321 005 20251116181544.0 010 $a1-60741-095-8 035 $a(CKB)2550000001041272 035 $a(EBL)3018321 035 $a(SSID)ssj0000834890 035 $a(PQKBManifestationID)11457437 035 $a(PQKBTitleCode)TC0000834890 035 $a(PQKBWorkID)10981631 035 $a(PQKB)10070151 035 $a(MiAaPQ)EBC3018321 035 $a(Au-PeEL)EBL3018321 035 $a(CaPaEBR)ebr10660182 035 $a(OCoLC)923658145 035 $a(BIP)27924937 035 $a(EXLCZ)992550000001041272 100 $a20100203d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAngiotensin converting enzyme inhibitors /$fAnne N. DeBrue, editor 205 $a1st ed. 210 $aNew York $cNova Biomedical Books$dc2009 215 $a1 online resource (252 p.) 300 $aDescription based upon print version of record. 311 08$a1-60692-619-5 320 $aIncludes bibliographical references and index. 327 $a""ANGIOTENSIN CONVERTING ENZYME INHIBITORS ""; ""Contents ""; ""Preface ""; ""Angiotensin Converting Enzyme Inhibitors ""; ""Abstract ""; ""Introduction a??? The Components of the Renin Angiotensin Aldosterone System (RAAS)""; ""Structure and Structure Activity Relationships of the ACEIs ""; ""Clinical Indications and Uses of the ACEIs ""; ""Adverse Effects of the ACE Inhibitors with Special Reference to Worsening Renal Failure in CKD Patients ""; ""Conclusion/Post-Script ""; ""References ""; ""Adverse Effects of Angiotensin-Converting Enzyme Inhibitor: A Review of the Literature "" 327 $a""Abstract """"Introduction ""; ""ACEI-Associated Cough ""; "" Hypersensitivity Reaction During Hemodialysis ""; ""ACEI-Associated Anemia ""; ""ACEI-Induced Lung Disease ""; ""References ""; ""Plant-Derived Substances as ACE Inhibitors a??? Biosynthesis-Activity Relationship of Flavonoids, Terpenes and Sterols on Angiotensin-Converting Enzyme Activity in Human Endothelial Cells ""; ""Abstract ""; ""Introduction ""; ""Aim of this Study ""; ""Material and Methods ""; ""Results (Table 1) ""; ""Conclusion ""; ""Acknowledgments ""; ""References "" 327 $a""The Proper Use of Angiotensin-Converting Enzyme Inhibitors in Patients with Chronic Kidney Disease """"Abstract""; ""Introduction ""; ""Effects of ACE inhibitors on Renal and Glomerular Hemodynamics ""; ""Effects of ACE Inhibitors on Proteinuria ""; ""Increasing the Doses of ACE Inhibitors or the Addition of ARB? ""; ""Excretion and Plasma Concentration of ACE Inhibitors in Patients with Chronic Renal Failure ""; ""Upper Limit of Serum Creatinine to Add on ACE Inhibitor ""; ""Long-Term Renoprotective Effects and Escape Phenomenon by Use of ACE Inhibitors "" 327 $a""Side Effects of ACE Inhibitors in Patients with Chronic Renal Failure """"Influence of Gene Polymorphisms on Renoprotective Effects of ACE Inhibitors ""; ""Compliance of Taking ACE Inhibitors ""; ""Additional Therapy with ACE Inhibitors ""; ""Clinical Approach for Proper Use of ACE Inhibitors ""; ""Summary ""; ""Patients and Methods ""; ""Acknowledgements ""; ""References ""; ""Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function ""; ""Abstract ""; ""Abbreviation: ""; ""* Median follow-up "" 327 $a""Potential Mechanisms of ACEI Beneficial Activity in Patients with CAD """"Clinical Uses of ACEI in Cardiovascular Diseases ""; ""Randomized Clinical Trials Examining the Use of ACEI in Patients with CAD and Preserved LV Systolic Function ""; ""Ischemia Management with Accupril Post Bypass Graft via Inhibition of Angiotensin Converting Enzyme (IMAGINE) Trial ""; ""Meta Analysis of the Effects of ACEI in Patients with Normal LV Function and CAD ""; ""Putting it Together ""; ""References "" 327 $a""Dual Blockade of the Renin-Angiotensin System: Angiotensin Converting Enzyme Inhibition, Angiotensin Receptor Blockade and Renin Inhibition"" 330 $aAngiotensin II is a very potent chemical that causes the muscles surrounding blood vessels to contract, thereby narrowing the vessels. The narrowing of the vessels increases the pressure within the vessels causing high blood pressure (hypertension). This book presents important research in this field. 606 $aAngiotensin converting enzyme$xInhibitors 606 $aKidneys$xDiseases$xChemotherapy 615 0$aAngiotensin converting enzyme$xInhibitors. 615 0$aKidneys$xDiseases$xChemotherapy. 676 $a572/.744 701 $aDeBrue$b Anne N$01871669 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910959306703321 996 $aAngiotensin converting enzyme inhibitors$94480572 997 $aUNINA